Phenotypic Changes Occurring during in vitro Activation of Human Splenic B Lymphocytes

  • Andrew W. Boyd
  • Arnold S. Freedman
  • Kenneth C. Anderson
  • David C. Fisher
  • Jack C. Horowitz
  • John F. Daley
  • Stuart F. Schlossman
  • Lee M. Nadler


The present study had two motivations: first to develop a system in which normal B cell differentiation could be studied in vitro. Second, to find out which antigens were the hallmarks of individual events in B cell develop-ment, with the hope that likely candidates for receptors could be identified. We show that highly purified splenocytes can be activated by anti-Ig antibody in vitro (1–2) and the phenotypic changes induced by activation defined. When T cell help was provided, these cells could be driven to differentiate (produce Ig) and a further characteristic set of phenotypic changes were shown to occur. Finally, an example is given of how this system can be used to study the function of one of the receptors (IL-2 receptor) induced by activation.


Phenotypic Change Cell Blast Hairy Cell Leukemia Thymidine Uptake Complement Lysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fothergill, J.J., R. Wistar, J.N. Woody, and D.C. Parker. 1982. A mitogen for human B cells: Anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells. J. Immunol. 128: 1945.PubMedGoogle Scholar
  2. 2.
    Muraguchi, A., J.L. Butler, J.M. Kehrl, and A.S. Fauci. 1983. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by monoclonal B cell growth factor. J. Exp. Med. 157: 530.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson, K.C., A.W. Boyd, D.C. Fisher, B.L. Slaughenhoupt, J. Groopman, C. O’Hara, J. Daley, S.F. Schlossman, and L.M. Nadler. 1985. Distinct subsets of human B cells defined by the expression of B1 and B2 antigens. J. Immunol. 134: 820.PubMedGoogle Scholar
  4. 4.
    Yokochi, T., R.D. Holly, and E.A. Clark. 1982. B lymphocyte antigen (BB-1) expressed on Epstein Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt’s lymphomas. J. Immunol. 128: 823.PubMedGoogle Scholar
  5. 5.
    Thorley-Lawson, D.A., R.T. Schooley, A.K. Bhan, and L.M. Nadler. 1982. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30: 415.CrossRefGoogle Scholar
  6. 6.
    Fox, D.A., R.E. Hussey, K.A. Fitzgerald, A. Bensussan, J.F. Daley, S.F. Schlossman, and E.L. Reinherz. 1985. Activation of human thymocytes via the 50kd Til sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3-positive and T3-negative populations. J. Immunol. 134: 330.PubMedGoogle Scholar
  7. 7.
    Meuer, S.C., R.E. Hussey, M. Fabbi, D. Fox, O. Acuto, K.A. Fitzgerald, J.C. Hodgdon, J.P. Protentis, S.F. Schlossman, and E.L. Reinherz. 1984. An alternative pathway of T cell activation: A functional role for the 50kd Til sheep erythrocyte receptor protein. Cell 36: 897.PubMedCrossRefGoogle Scholar
  8. 8.
    Boyd, A.W., J.W. Goding, and J.W. Schrader. 1981. Regulation of growth and differentiation of a murine B cell hybridoma. I. Lipopolysaccharide induced different actions. J. Immunol. 126: 246.Google Scholar
  9. 9.
    Maizel, A.C., Sahasrabuddhe, S. Mehta, J. Morgan, L. Lachman, and R. Ford. 1982. Biochemical separation of a human B cell mitogenic factor. Proc. Natl. Acad. Sci. U.S.A. 79: 5998.PubMedCrossRefGoogle Scholar
  10. 10.
    Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamoaka, and W.E. Paul. 1982. Identification of a B cell growth factor distinct from interleukin 2. J. Exp. Med. 15: 914.CrossRefGoogle Scholar
  11. 11.
    DeFranco, A.L., E.S. Raveche, R. Asofsky, and W.E. Paul. 1982. Frequency of B lymphocytes response to anti-immunoglobulin. J. Exp. Med. 155: 1523.PubMedCrossRefGoogle Scholar
  12. 12.
    Kehrl, J.H., A Muraguchi, and A.S. Fauci. 1984. Human B cell activation and cell cycle progression stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Eur. J. Immunol. 14: 115.PubMedCrossRefGoogle Scholar
  13. 13.
    Korsmeyer, S.J., W.C. Greene, J. Cossman, S.M. Hsu, J.P. Jensen, L.M. Neckers, S.L. Marshall, A. Bakshi, J.M. Depper, W.J. Leonard, E.S. Jaffe, and T.A. Waldmann. 1983. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. U.S.A. 80: 4522.PubMedCrossRefGoogle Scholar
  14. 14.
    Malek, T.R., R. Robb, and E. Shevach. 1983. Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. U.S.A. 80: 5694.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsudo, M., T. Uchiyama, and H. Uchino. 1984. Expression of the Tac antigen on normal human B cells. J. Exp. Med. 160: 612.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • Andrew W. Boyd
  • Arnold S. Freedman
  • Kenneth C. Anderson
  • David C. Fisher
  • Jack C. Horowitz
  • John F. Daley
  • Stuart F. Schlossman
  • Lee M. Nadler

There are no affiliations available

Personalised recommendations